Krka Reaches Out-of-Court Settlement Over Perindopril
Novo Mesto, 3 November - Pharma company Krka has reached an out-of-court settlement with France's Les Laboratoires Servier over a type of the active ingredient perindopril. Under the deal, Krka will be allowed to sell drugs containing the active ingredient in several European countries, although not in the United Kingdom.
The rest of this news item is available to subscribers.
The news item consists of 1.082 characters (without spaces) or 206 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.